Tifcemalimab
Product Specifications
CAS Number
2236068-83-8
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.99
Bioactivity
Tifcemalimab (JS004) is a humanised antibody targeting BTLA (B and T lymphocyte attenuator), which binds to BTLA and blocks the interaction between HVEM and BTLA, exhibiting immunomodulatory and antitumour activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1410079 Inquire
Recombinant Human Zinc finger protein 462 (ZNF462) , partial
Sign In for Pricing
View Details 
147091 50 µg
ORAI2, Control Peptide (CAP-Binding Protein Complex-Interacting Protein 2)
Sign In for Pricing
View Details